Welcome to the e-CCO Library!

P457: Long-term follow-up of patients with IBD after switching from original adalimumab to adalimumab biosimilar during COVID 19 pandemic
Year: 2021
Source: ECCO'21 Virtual
Authors: Klimova, K.(1);Padilla Suarez, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P457: Rapid faecal calprotectin test and symptom index for monitoring the disease activity in colonic IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Puolanne A.-M.*1, Kolho K.-L.2, Färkkilä M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P457: Treatment duration of ustekinumab in patients with Crohn's disease (CD) and psoriasis (PSO) – real-world evidence from German claims data
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kosa, F.(1);Nair, S.(1);He, J.(1);Lin, X.(1);Di Scala, L.(1);Lehne, M.(2)*;Ghiani, M.(3);Maywald, U.(4);Wilke, T.(3);
Created: Friday, 14 July 2023, 11:05 AM
P458 Association between adalimumab serum levels and level of remission in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Hambli1, S. Rogeau2, N. Duveau3, M. Nachury1, J. Branche1, R. Gérard1, P. Wils1, C. Lauriot Dit Prevost1, T. Lambin1, P. Desreumaux1, M. Labalette2, B. Pariente1

Created: Thursday, 30 January 2020, 10:12 AM
P458: Effect of cognitive behavioural therapy on clinical disease course in adolescents and young adults with inflammatory bowel disease and subclinical anxiety and/or depression: results of a randomised trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. van den Brink1, L. Stapersma2, A. S. Bom1, D. Rizopolous3, J. van der Woude4, R. Stuyt5, D. Hendriks6, J. van der Burg6, R. Beukers7, T. Korpershoek7, S. Theuns7, E. Utens2,8,9, J. Escher*1

Created: Friday, 22 February 2019, 9:41 AM
P458: Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU.
Year: 2021
Source: ECCO'21 Virtual
Authors: Mesonero Gismero, F.(1);Zabana, Y.(2);Fernández-Clotet, A.(3);Núñez, A.(4);Caballol, B.(3);Sola, A.(4);García, M.J.(5);Bertoletti, F.(6);Mínguez, A.(7);Suris, G.(8);Casis, B.(9);Ferreiro-Iglesias, R.(10);Calafat, M.(11);Jiménez, I.(12);Miranda-Bautista, J.(13);Lamuela, L.J.(14);Fajardo, I.(15);Torrealba, L.(16);Nájera, R.(17);Sáiz, R.M.(18);González, I.(19);Vicuña, M.(20);García-Morales, N.(21);Gutiérrez, A.(22);López-García, A.(23);Benítez, J.M.(24);Rubín de Célix, C.(25);Tejido, C.(26);Brunet, E.(27);Hernández, A.(28);Suárez, C.(29);Piquqeras, M.(30);Castaño, A.(31);Ramos, L.(32);Sobrino, A.(33);Rodríguez-Grau, M.C.(34);Elosua, A.(35);Montoro, M.(36);López-Sanromán, A.(1);Barreiro-de Acosta, M.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P458: Long-term outcome of Crohn’s disease complicated by upper gastrointestinal stricture: A GETAID cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Lambin1*, A. Amiot2, J.M. Gornet3, P. Seksik4, D. Laharie5, E. Louis6, C. Giletta7, J. Filippi8, M. Fumery9, G. Cadiot10, G. Pineton de Chambrun11, S. Nahon12, M. Serrero13, B. Coffin14, L. Plastaras15, S. Viennot16, N. Dib17, L. Peyrin-Biroulet18, B. Pariente1

Created: Thursday, 21 February 2019, 9:14 AM
P458: Low adherence to Mediterranean diet is associated with increased adipose tissue in patients with ulcerative colitis (UC) after pouch surgery: a cross sectional study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pfeffer-Gik, T.(1)*;Godny, L.(1);Ollech, J.(1);Wasserberg, N.(2);White, I.(2);Cohen, S.(1);Broitman, Y.(1);Avni-Biron, I.(1);Banai, H.(1);Snir, Y.(1);Yanai, H.(1);Yackobovich Gavan, M.(3,4);Shimon, I.(5);Tsvetov, G.(5);Barkan, R.(1);Dotan, I.(1);
Created: Friday, 14 July 2023, 11:05 AM
P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD audit
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. St. Clair Jones*1, S. Murray2

Created: Friday, 22 February 2019, 9:49 AM
P458: Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN
Year: 2022
Source: ECCO'22
Authors: Yerushalmy-Feler, A.(1);Pujol-Muncunill, G.(2);Martin-de-Carpi, J.(2);Kolho, K.L.(3);Levine, A.(4);Olbjørn, C.(5);Granot, M.(6);Bramuzzo, M.(7);Jonsson Rolandsdotter8, H.(8);Mouratidou, N.(9);Hradsky, O.(10);Scarallo, L.(11);Matar, M.(12);Magen Rimon, R.(13);Rinawi, F.(14);Shalem, T.(15);Najajra, H.(16);de Meij, T.(17);Aloi, M.(18);Velasco Rodríguez-Belvís, M.(19);Alvisi, P.(20);Schneider, A.M.(21);van Rheenen, P.(22);Navas-López, V.M.(23);Kiparissi, F.(24);Barrio, J.(25);Turner, D.(26);Cohen, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P458: Sleep problems in inflammatory bowel disease; When bed becomes a battleground
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Green A.*1, Beale A.2, Fraser A.3, Potokar J.3, Durrant C.1, Barnes M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P459 The impact of latent cytomegalovirus infection on the disease behaviour in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Långvall1, C. Shi1, P. Karling2

Created: Thursday, 30 January 2020, 10:12 AM
P459: Change in the expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Jójárt, B.(1);Molnár, T.(2);Szabó, V.(1);Varga, Á.(1);Resál, T.(3);Szántó, K.(3);Kata, D.(4);Földesi, I.(4);Molnár, T.(3);Maléth, J.(5);Farkas, K.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P459: High inadequate surveillance rates in colitis-associated advanced neoplasia: a multicenter retrospective cohort study
Year: 2022
Source: ECCO'22
Authors: Te Groen , M.(1);Derks , M.E.(1);Peters , C.P.(2);Dijkstra , G.(3);De Vries , A.C.(4);Römkens , T.E.(5);Horjus , C.S.(6);De Boer , N.K.(7);De Jong , M.E.(1);Nagtegaal , I.D.(8);Derikx , L.A.(1);Hoentjen , F.(1,9);
Created: Friday, 11 February 2022, 3:52 PM
P459: Hospitalization, use of biologics and surgery rates in inflammatory bowel diseases: a single-center comparative analysis between public and private healthcare systems in a tertiary unit from Latin America
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zacharias, P.(1);Perussolo, M.(2);Magro, D.O.(3);Barauna, F.D.S.B.(2);KotzeMD- PhD, P.G.(4)*;
Created: Friday, 14 July 2023, 11:05 AM
P459: Obesity in patients with an ileoanal pouch due to ulcerative colitis is not associated with an increased risk for pouchitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pfeffer-Gik T.*1, Fishman S.1, Godny L.1, Tulchinsky H.2, Dotan I.1

Created: Wednesday, 20 February 2019, 10:36 AM
P459: Persistent mesorectal inflammatory activity is associated with complications after proctectomy in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.J. de Groof1, J.H. van der Meer2,3*, P.J. Tanis1, J.R. de Bruyn2,3, O. van Ruler1, G.R. D'Haens3, G.R. van den Brink2,3,4, W.A. Bemelman1, M.E. Wildenberg2,3, C.J. Buskens1

Created: Thursday, 21 February 2019, 9:14 AM
P459: Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Iborra*1, B. Navarro1, X. Cortes2, M. Boscá3, T. Blazquez1, J. Herreras1, G. Trejo3, B. Beltrán1, P. Nos1

Created: Friday, 22 February 2019, 9:49 AM
P459: Vedolizumab for the treatment of chronic pouchitis: the Edinburgh experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Cesano*1,2, G. R. Jones2, P. W. Jenkinson2, A. G. Shand2, C. W. Lees2, I. D. Arnott2, N. Plevris2

Created: Friday, 22 February 2019, 9:41 AM
P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Clarke, J. Di Paolo, B. Downie, A. Meng, N. Mollova, Y. Yu, P. Han

Created: Thursday, 30 January 2020, 10:12 AM